A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors
2022 · Frontiers in Immunology · 49 citations
https://doi.org/10.3389/fimmu.2022.826337
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
673
Citations
13
h-index
16
i10-index
Honghai Xu is an academic researcher from Anhui Medical University. The author has contributed to research in topics: Viral Infections and Vectors & Ferroptosis and cancer prognosis & Osteoarthritis Treatment and Mechanisms. The author has an h-index of 13, co-authored 27 publications.
https://doi.org/10.3389/fimmu.2022.826337
https://doi.org/10.1007/s00264-013-1937-y
https://doi.org/10.20964/2020.08.56
https://doi.org/10.1007/s12672-025-04016-7
Click to start Chat